Alexion Pharmaceuticals, Inc. provided earnings guidance for the year 2014. The company announced that financial guidance for 2014 remains unchanged with revenue growing at 38% and non-GAAP EPS growing at 56%. And that excludes $88 million in prior year sales in France.
1st Jan change | Capi. | |
---|---|---|
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |